Back
Results - Announcements
Nephrocare Health Services Ltd consolidated sales up 6.07% on year in Q2FY2026, net profit grew slightly 5.27%
11-Aug-2026, 08:51
Nephrocare Health Services Ltd share price ticked higher by 0.28% to Rs 696.15 after the company's net profit inched up 5.27% to Rs 31.97 crore, while revenue from operations slightly gained 6.07% to Rs 281.75 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 72255.77 crore, improving 10.15%. It has improved by 2.19% over last one week and surged by 17.19% in last one month while the market capitalization of Nephrocare Health Services Ltd has remained flat Profit before tax (PBT) of Nephrocare Health Services Ltd stood at Rs 41.03 crore in Q2 FY26, rallying 43.86% year-on-year, and surging by 23.51% quarter-on-quarter. EBITDA came in at Rs 56 crore, expanding by 37.64% YoY and jumping 33.70% sequentially. Total expenses grew marginally by 1.99% to Rs 242.41 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 62.44 crore, inching up 4.71% YoY, while employee benefits expense was at Rs 47.83 crore, easing 4.14% YoY. For the TTM ended FY26, revenue from operations jumped by 32.16% to Rs 998.85 crore, while net profit registered a growth of 14.52% to Rs 76.84 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 16974% to Rs 202.46 crore, and PBT rose 11.47% to Rs 97.47 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 232.58 crore in FY26, as against Rs 135.35 crore in FY25. Nephrocare Health Services Ltd surged by 47.61% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.56% during the same period.
Nephrocare Health Services Ltd share price ticked higher by 0.28% to Rs 696.15 after the company's net profit inched up 5.27% to Rs 31.97 crore, while revenue from operations slightly gained 6.07% to Rs 281.75 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 72255.77 crore, improving 10.15%. It has improved by 2.19% over last one week and surged by 17.19% in last one month while the market capitalization of Nephrocare Health Services Ltd has remained flat Profit before tax (PBT) of Nephrocare Health Services Ltd stood at Rs 41.03 crore in Q2 FY26, rallying 43.86% year-on-year, and surging by 23.51% quarter-on-quarter. EBITDA came in at Rs 56 crore, expanding by 37.64% YoY and jumping 33.70% sequentially. Total expenses grew marginally by 1.99% to Rs 242.41 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 62.44 crore, inching up 4.71% YoY, while employee benefits expense was at Rs 47.83 crore, easing 4.14% YoY. For the TTM ended FY26, revenue from operations jumped by 32.16% to Rs 998.85 crore, while net profit registered a growth of 14.52% to Rs 76.84 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 16974% to Rs 202.46 crore, and PBT rose 11.47% to Rs 97.47 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 232.58 crore in FY26, as against Rs 135.35 crore in FY25. Nephrocare Health Services Ltd surged by 47.61% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.56% during the same period.